Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Salusin-β mediate neuroprotective effects for Parkinson's disease

Journal Article · · Biochemical and Biophysical Research Communications
; ;  [1];  [2];  [3];  [1]
  1. Laboratory of Stem Cells and Cell Reprogramming, Department of Biomedical Engineering (BK21 plus), Dongguk University, 30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620 (Korea, Republic of)
  2. Acupuncture and Meridian Science Research Center, Department of Korean Medical Science, Graduate School of Korean Medicine, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447 (Korea, Republic of)
  3. Department of Biomedical Sciences, Center for Creative Biomedical Scientists, Chonnam National University, Gwangju, 61469 (Korea, Republic of)
Neuropeptides, small peptides found in many mammalian brain, play key roles in communicating with each other to modulate neuronal activity. Here, we reported that endogenous neuropeptide salusin-β has neuroprotective effects on the midbrain dopamine neurons and can be used as an effective therapeutic treatment for Parkinson's disease (PD). We found that the MrgprA1 receptor mediates the neuroprotective effects of salusin-β on the midbrain dopamine neurons. Importantly, intranasal administration of salusin-β in a PD mouse model show the neuroprotection of dopaminergic neurons and increased the survival of midbrain dopamine neurons. Furthermore, inhibition of the salusin-β receptor, MrgprA1, abolished the neuroprotective effects induced by salusin-β. Taken together, these results demonstrate the novel role of salusin-β in the central nervous system and salusin-β can be used as a novel therapeutic to effectively treat PD.
OSTI ID:
23134348
Journal Information:
Biochemical and Biophysical Research Communications, Journal Name: Biochemical and Biophysical Research Communications Journal Issue: 3 Vol. 503; ISSN BBRCA9; ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
Journal Article · Thu Aug 16 20:00:00 EDT 2018 · Neural Regeneration Research · OSTI ID:1628698

Pre-clinical therapeutic development of a series of metalloporphyrins for Parkinson's disease
Journal Article · Sat Jul 01 00:00:00 EDT 2017 · Toxicology and Applied Pharmacology · OSTI ID:22690997

Nurr1 overexpression exerts neuroprotective and anti-inflammatory roles via down-regulating CCL2 expression in both in vivo and in vitro Parkinson's disease models
Journal Article · Sat Jan 21 23:00:00 EST 2017 · Biochemical and Biophysical Research Communications · OSTI ID:22696806